Alana Letourneau

Chief Clinical Strategy Officer at Carisk Partners

Dr. Alana Letourneau is an NJBiz 40 Under 40 Award recipient with demonstrated experience in clinical operations, data analytics, health technology and neuroscience research. Dr. Letourneau is responsible for overseeing the Physician, Quality, and Clinical Data/Technology teams across Carisk Partners lines of business.

Previously, Dr. Letourneau conducted neuroscience research at the nation’s leading academic and government institutions. At Princeton University, she led the first neuroimaging study examining visual cortex neuroplasticity as a temporal receptive window hierarchy in the congenitally blind. This study led to her induction into the Society of Sigma Xi International Research Honor Society and presentation of study results at the world’s largest neuroscience conference. At the National Institutes of Health, she conducted two independent neuroimaging studies within an epilepsy population, publishing results and presenting at the American Epilepsy Society Conference. At New York University School of Medicine, Dr. Letourneau published the first study examining the effects of traumatic brain injury on health outcomes in survivors of torture and was the youngest presenter at the largest national conference for torture treatment programs.

Dr. Letourneau earned her Medical Degree (MD) at New York University School of Medicine, where she was named a Raymond Brienza Scholar, Department of Medicine Awardee in Healthcare Dilemmas and Health Disparities Research Fellow. She earned a Master of Business Administration (MBA) from New York University Stern School of Business, where she specialized in the Management of Technology and Operations with an emphasis in data analytics. At Stern, she was the recipient of the Armando John Garville Scholarship and named to the Dean’s List. Dr. Letourneau also earned a Bachelor of the Arts (BA) from Princeton University, where she majored in Psychology, concentrated in Neuroscience and minored in Global Health and Health Policy; she graduated summa cum laude from Princeton and was awarded the George A. Miller Cognitive Science Prize, Global Health Senior Thesis Prize, Scheide Scholarship and Henry Luce Scholarship.

Links

Timeline

  • Chief Clinical Strategy Officer

    January, 2021 - present

View in org chart